Allarity Therapeutics, Inc. Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge
Allarity Therapeutics, Inc. (ALLR) reported Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge of $2.69 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement › Other Income
us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 · last filed 2023-08-14
| Period end | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 6 month | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 12 month |
|---|---|---|
| 2023-06-30 | $2.69M 10-Q · filed 2023-08-14 | |
| 2022-12-31 | $2.64M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |